Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-02-18
2011-11-22
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S119000
Reexamination Certificate
active
08063064
ABSTRACT:
The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein A is A2 and R1, R2, R3, R4a, R4b, R5, R6, Ar, X1, X2, X4, X4and X5are as herein defined. Also disclosed in the present invention are methods of treating an HIV infection with compounds defined herein and pharmaceutical compositions containing said compounds.
REFERENCES:
patent: 7166738 (2007-01-01), Dunn et al.
patent: 7189718 (2007-03-01), Dunn et al.
patent: 7208509 (2007-04-01), Dunn et al.
patent: 7241794 (2007-07-01), Dunn et al.
patent: 2005/0054707 (2005-03-01), Edwards et al.
patent: 2005/0215554 (2005-09-01), Dunn et al.
patent: 2005/0239880 (2005-10-01), Dunn et al.
patent: 2006/0025462 (2006-02-01), Dunn et al.
patent: 2006/0069261 (2006-03-01), Bonneau et al.
patent: 2006/0223874 (2006-10-01), Martin et al.
patent: 2007/0021442 (2007-01-01), Saggar et al.
patent: 2007/0078128 (2007-04-01), Saito et al.
patent: 2007/0088015 (2007-04-01), Silva et al.
patent: 2007/0088053 (2007-04-01), Mirzadegan et al.
patent: 2010/0256356 (2010-10-01), Blake et al.
patent: 2010/0292196 (2010-11-01), Rudra et al.
patent: 2010/0317646 (2010-12-01), Mciver et al.
patent: WO 02/04424 (2002-01-01), None
patent: WO 02/30907 (2002-04-01), None
patent: WO 02/085860 (2002-10-01), None
patent: WO 02/100853 (2002-12-01), None
patent: WO 2004/029042 (2004-04-01), None
patent: WO 2004/029051 (2004-04-01), None
patent: WO 2004/031156 (2004-04-01), None
patent: WO 2004/031178 (2004-04-01), None
patent: WO 2004/085411 (2004-10-01), None
patent: WO 2005/090317 (2005-09-01), None
patent: WO 2006/067587 (2006-06-01), None
Chan, J. H. et. al., “Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1,”J. Med Chem.2004, vol. 47, pp. 1175-1182.
Genin, M. J., et. al., “Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives,”Journal Med. Chem.2000, vol. 43, pp. 1034-1040.
Romines, K. R., et. al., “Structure-Activity Relationship Studies of Novel Benzophenones leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitors,” J. Med. Chem. 2006, vol. 49, pp. 727-739.
Wyatt, P. G. et. al., “Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,”Journal Med. Chem.1995, vol. 38, pp. 1657-1665.
Kennedy-Smith Joshua
Palmer Wylie Solang
Sweeney Zachary Kevin
Buckwalter Brian L.
Jaisle Cecilia M
Roche Palo Alto LLC
Wilson James O
LandOfFree
Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293775